Your browser is no longer supported. Please, upgrade your browser.
GRFS Grifols, S.A. daily Stock Chart
Grifols, S.A.
Index- P/E31.58 EPS (ttm)0.60 Insider Own- Shs Outstand684.14M Perf Week-8.99%
Market Cap12.95B Forward P/E12.88 EPS next Y1.47 Insider Trans- Shs Float- Perf Month-8.68%
Income- PEG2.79 EPS next Q0.37 Inst Own53.68% Short Float- Perf Quarter-11.58%
Sales- P/S- EPS this Y14.40% Inst Trans- Short Ratio1.96 Perf Half Y-17.52%
Book/sh3.56 P/B5.32 EPS next Y8.90% ROA- Target Price26.75 Perf Year5.75%
Cash/sh- P/C- EPS next 5Y11.30% ROE- 52W Range13.40 - 25.73 Perf YTD-18.72%
Dividend0.44 P/FCF- EPS past 5Y2.78% ROI- 52W High-26.43% Beta-
Dividend %2.32% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low41.27% ATR0.73
Employees24040 Current Ratio- Sales Q/Q11.80% Oper. Margin- RSI (14)40.11 Volatility3.42% 3.62%
OptionableYes Debt/Eq- EPS Q/Q63.00% Profit Margin- Rel Volume1.08 Prev Close18.76
ShortableYes LT Debt/Eq- EarningsMar 26 Payout- Avg Volume1.00M Price18.93
Recom1.70 SMA20-4.64% SMA50-4.56% SMA200-11.98% Volume1,086,899 Change0.91%
Mar-25-20Downgrade Citigroup Buy → Neutral
Jun-27-19Upgrade JP Morgan Neutral → Overweight
Feb-08-19Downgrade Berenberg Buy → Hold
Oct-11-18Upgrade Berenberg Hold → Buy
Jun-01-18Initiated Barclays Overweight
Oct-31-17Initiated Citigroup Buy
Jun-30-17Downgrade Goldman Buy → Neutral
Apr-06-17Initiated BofA/Merrill Buy
Jan-03-17Upgrade JP Morgan Neutral → Overweight
Feb-09-16Upgrade Berenberg Hold → Buy
Jan-04-16Downgrade Morgan Stanley Equal-Weight → Underweight
Dec-02-15Downgrade HSBC Securities Buy → Hold
Nov-20-15Downgrade Berenberg Buy → Hold
Apr-28-15Downgrade Berenberg Buy → Hold
May-26-20 09:00AM  Racing Against Time, Medical Researchers, Life Science Companies and COVID-19 Survivors Launch National Campaign to Drive Blood Plasma Donation PR Newswire
May-07-20 12:06PM  Repro-Med Systems (KRMD) Q1 2020 Earnings Call Transcript Motley Fool
09:00AM  Grifols Procleix Panther System with Automation Ready Technology (ART) receives FDA Approval PR Newswire
Apr-28-20 09:00AM  Grifols launches new 3-mL (900-IU) vial for high-potency HyperRAB® (rabies immune globulin [human]) PR Newswire
Apr-27-20 11:40AM  GRFS vs. ZTS: Which Stock Should Value Investors Buy Now? Zacks
Apr-20-20 02:53PM  Why a JoCo facility could soon be mass producing a COVID-19 treatment American City Business Journals
09:00AM  People Who Have Recovered from COVID-19 Can Now Donate their Convalescent Plasma in select Grifols U.S. Plasma Donor Centers PR Newswire
01:27AM  Here's Why I Think Grifols (BME:GRF) Might Deserve Your Attention Today Simply Wall St.
Apr-09-20 11:40AM  GRFS vs. ZTS: Which Stock Should Value Investors Buy Now? Zacks
Apr-06-20 09:30AM  Grifols 2019 Annual Report on Form 20-F Filed With the SEC on April 6, 2020 PR Newswire
Mar-31-20 10:12AM  How Grifols (GRFS) Stock Stands Out in a Strong Industry Zacks
Mar-26-20 08:23AM  The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Xencor Licenses Tech To Vir For COVID-19 Treatment, Delay In Pfizer's Upjohn-Mylan Merger Benzinga +9.85%
Mar-25-20 05:25PM  Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19 PR Newswire
03:55PM  Spain's Grifols to test plasma therapy for COVID-19 with U.S. FDA Reuters
Mar-21-20 12:52PM  Coronavirus Toll Surges in Spain
Mar-18-20 11:48AM  Hedge Funds Were Dumping Grifols SA (GRFS) Before The Coronavirus Insider Monkey
Mar-05-20 12:00PM  Grifols (GRFS) Upgraded to Strong Buy: Here's What You Should Know Zacks
09:34AM  New Strong Buy Stocks for March 5th Zacks
Feb-27-20 11:40AM  GRFS or IONS: Which Is the Better Value Stock Right Now? Zacks
Feb-21-20 07:52AM  Can You Imagine How Grifols's (BME:GRF) Shareholders Feel About The 85% Share Price Increase? Simply Wall St.
Feb-19-20 07:21AM  The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA Benzinga
Feb-18-20 07:37AM  The Triangle's big slice of NC bio/pharma pie List Insights American City Business Journals
Feb-13-20 09:00AM  Grifols PharmacyKeeper ranked No. 1 in KLAS rating, extends category leadership PR Newswire
Feb-11-20 11:40AM  GRFS vs. IONS: Which Stock Is the Better Value Option? Zacks
Feb-10-20 05:00AM  Family Builds $3.8 Billion Fortune, One Pint of Blood at a Time Bloomberg
Jan-06-20 11:07PM  Need To Know: Grifols, S.A. (BME:GRF) Insiders Have Been Buying Shares Simply Wall St.
Dec-12-19 09:24AM  Grifols launches XEMBIFY® (immune globulin subcutaneous human-klhw) 20%, a new Primary Immunodeficiency treatment PR Newswire
Dec-09-19 10:22AM  Hedge Funds Have Never Been This Bullish On Grifols SA (GRFS) Insider Monkey
Dec-06-19 03:42PM  Grifols presents its latest Alzheimer's clinical trial data PR Newswire
Dec-05-19 10:26AM  Grifols Streamlines Hospital Pharmacy Operations With New KIRO Fill® Technology and PharmacyKeeper Enhancements PR Newswire
Dec-02-19 09:17AM  Grifols to present latest Alzheimer's clinical trial results PR Newswire
Nov-19-19 06:27AM  Is Grifols (BME:GRF) A Risky Investment? Simply Wall St.
Nov-07-19 10:00AM  Grifols introduces AlphaID, a free cheek swab to screen for Alpha-1, the most common genetic form of COPD PR Newswire
Oct-14-19 01:22AM  Is Grifols, S.A.'s (BME:GRF) ROE Of 12% Impressive? Simply Wall St.
Oct-11-19 11:15AM  Hedge Funds Have Never Been This Bullish On Grifols SA (GRFS) Insider Monkey
Sep-16-19 01:54AM  Is Grifols, S.A. (BME:GRF) Worth 27.10 Based On Its Intrinsic Value? Simply Wall St.
Aug-23-19 04:08AM  Should Grifols (BME:GRF) Be Disappointed With Their 61% Profit? Simply Wall St.
Jul-31-19 04:54AM  Is Grifols, S.A.'s (BME:GRF) 1.2% Dividend Worth Your Time? Simply Wall St.
Jul-16-19 02:39AM  Grifols presents additional encouraging Alzheimer's trial results at AAIC PR Newswire
Jul-08-19 09:22AM  Company News for Jul 8, 2019 Zacks
05:06AM  How Much Are Grifols, S.A. (BME:GRF) Insiders Spending On Buying Shares? Simply Wall St.
Jul-05-19 04:17PM  This Pharma Stock Dodged A Broad Slide For Drugmakers Here's Why Investor's Business Daily
08:55AM  The Daily Biotech Pulse: FDA Approves Karyopharm's Blood Cancer Treatment, Grifols' Immunodeficiency Drug; ESMO, ISTH Conferences In The Spotlight Benzinga
Jul-04-19 11:51AM  Grifols Announces FDA Approval of Xembify®, 20% Subcutaneous Immunoglobulin for Primary Immunodeficiencies PR Newswire
Jul-03-19 05:00AM  Grifols Selected to Build Its First Intravenous Solutions Manufacturing Line in Africa PR Newswire
Jun-29-19 08:13PM  Is Grifols SA (GRFS) A Good Stock To Buy ? Insider Monkey
Jun-27-19 04:34PM  These European companies benefit from high health-care prices in the U.S. MarketWatch
Jun-19-19 09:00AM  Grifols to launch plasma-protein-based bleeding-control solutions PR Newswire
Jun-12-19 08:15AM  Is Rigel Pharmaceuticals a Buy? Motley Fool
Jun-06-19 06:39AM  Do Institutions Own Grifols, S.A. (BME:GRF) Shares? Simply Wall St.
May-20-19 06:43PM  George Soros' Top 6 New Buys of the 1st Quarter
May-09-19 09:30AM  GRFS or ORINY: Which Is the Better Value Stock Right Now? Zacks
May-08-19 12:23AM  Rigel Pharmaceuticals Inc (RIGL) Q1 2019 Earnings Call Transcript Motley Fool
Apr-30-19 06:00AM  Grifols Announces PharmacyKeeper Bidirectional Integration with Epic PR Newswire
Apr-29-19 12:00PM  Grifols Announces the Opening of its new Plasma Donor Center in Hinesville, Georgia PR Newswire
03:14AM  What Does Grifols, S.A.'s (BME:GRF) P/E Ratio Tell You? Simply Wall St.
Apr-18-19 09:00AM  Grifols US donor centers exceed 250,000 pounds of food collected PR Newswire
Apr-15-19 06:15AM  Grifols donations of blood clotting factor helping people with hemophilia globally PR Newswire
Apr-05-19 10:55AM  Grifols 2018 Annual Report on Form 20-F Filed With the SEC on April 5, 2019 PR Newswire
Apr-02-19 06:46AM  Grifols, S.A. (BME:GRF): What We Can Expect From This Growth Stock Simply Wall St.
Mar-31-19 12:17PM  Should You Buy Grifols SA (GRFS)? Insider Monkey
Mar-23-19 09:00AM  Grifols Announces the Opening of its new Plasma Donor Center in Russellville, AR PR Newswire
Mar-07-19 04:03AM  Spain's Grifols, China's Shanghai RAAS form strategic alliance Reuters
03:32AM  Blood Giant Grifols Acquires $1.9 Billion Stake in Shanghai RAAS Bloomberg
Mar-01-19 09:18AM  Rigel Pharmaceuticals (RIGL) Q4 2018 Earnings Conference Call Transcript Motley Fool
Feb-21-19 11:22AM  Grifols PharmacyKeeper Receives KLAS Category Leader Award for Third Consecutive Year PR Newswire
Feb-19-19 05:54PM  'Young blood' Alzheimer's treatments slapped with warning by FDA commissioner American City Business Journals
05:30PM  East Bay biotech with late-stage drug files for bankruptcy American City Business Journals
Feb-07-19 12:31PM  Grifols Receives FDA Approval for Procleix Babesia Assay for Donor Screening on Procleix Panther System PR Newswire
Feb-05-19 05:29AM  What To Know Before Buying Grifols, S.A. (BME:GRF) For Its Dividend Simply Wall St.
Jan-23-19 10:20AM  Rigel Rises On European Marketing Agreement For Autoimmune Drug Benzinga
07:51AM  Rigel Pharmaceuticals stock up 9% after announcing licensing agreement with Grifols MarketWatch
07:30AM  Rigel Pharmaceuticals Enters Collaboration and License Agreement with Grifols, S.A. to Commercialize Fostamatinib in Europe PR Newswire
Jan-08-19 07:37AM  Grifols receives FDA approval of Erytra Eflexis®, the latest advancement in scalable blood typing solutions PR Newswire
Jan-06-19 02:54AM  A Note On Grifols, S.A.s (BME:GRF) ROE and Debt To Equity Simply Wall St.
Dec-07-18 01:56AM  A Look At The Fair Value Of Grifols SA (BME:GRF) Simply Wall St.
Nov-22-18 09:13AM  Shanghai RAAS in tie-up talks with U.S. blood products arm of Spain's Grifols Reuters
07:51AM  BRIEF-Shanghai RAAS Blood Products Plans To Acquire Tiancheng (Germany), Spain's Grifols Diagnostic Solutions Reuters
05:44AM  BRIEF-Shanghai RAAS Blood Products Plans To Buy Germany's Biotest, Spain's Grifols Diagnostic Solutions Reuters
Oct-27-18 03:30AM  Grifols demonstrates a significant reduction (61%) in the progression of moderate Alzheimer's disease using its AMBAR treatment protocol PR Newswire
Oct-12-18 09:50AM  FDA Approves Grifols ID CORE XT Test For Molecular Red Blood Cell Typing PR Newswire
09:17AM  Grifols (GRFS) Surges: Stock Moves 5.4% Higher Zacks
Oct-08-18 02:57PM  Grifols Delivers Promise of Advancing Plasma-derived Medicines through Innovative Vision and Donor Support PR Newswire
Oct-03-18 11:52AM  Italian stocks lead Europe as budget deficit fears quelled Reuters
Sep-26-18 08:56AM  Recent Analysis Shows Green Plains Partners LP, Companhia Paranaense de Energia (COPEL), China Yuchai International, AerCap Holdings N.V., Northwest Natural Gas, and Grifols, S.A Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Sep-24-18 12:59PM  Grifols Announces the Opening of Biotest Pharmaceuticals Corporation's Newest Plasma Donor Center in Bowling Green, Ohio PR Newswire
Sep-17-18 09:35AM  Is Grifols, S.A. (GRFS) a Great Stock for Value Investors? Zacks
Sep-11-18 07:34AM  Who Owns Grifols SA (BME:GRF)? Simply Wall St.
Sep-07-18 01:30PM  Grifols: Just-approved medicine will only be manufactured in Clayton American City Business Journals
Aug-16-18 08:00AM  Grifols Achieves Key Milestone with FDA Approval of the New Consolidated Manufacturing Facility (CMF) for Production of Recombinant Proteins PR Newswire
Aug-14-18 08:00AM  Procleix® Zika Virus Assay Approved by the FDA for Blood Screening on the Procleix® Panther® System PR Newswire
Aug-01-18 11:36AM  Healthcare firm Grifols S.A. wins US antitrust nod to buy Biotest US Corp Reuters
Jun-27-18 02:23AM  What is Behind Grifols SAs (BME:GRF) Superior ROE? Simply Wall St.
Jun-22-18 07:30AM  Free Technical Research on ImmunoGen and Three More Biotech Equities ACCESSWIRE
Jun-19-18 08:25AM  Grifols Expands its NAT Solutions Portfolio with New FDA Approvals for Two Assays PR Newswire
Jun-15-18 02:39PM  2 Stable and 2 Speculative Biotech Stocks to Buy InvestorPlace
Jun-07-18 08:15AM  Factors of Influence in 2018, Key Indicators and Opportunity within Eldorado Gold, Lamar Advertising, Bitauto, Magellan Midstream Partners, Deutsche Bank Aktiengesellschaft, and Grifols, S.A. New Research Emphasizes Economic Growth GlobeNewswire
May-31-18 09:00AM  Grifols Launches a New Testing Service for Patients Treated with Daratumumab PR Newswire
May-25-18 01:46PM  Biotech and energy top list for best paying jobs Yahoo Finance Video
May-14-18 08:00AM  Grifols Expands its Blood Typing Solutions Portfolio in the United States with Antisera Reagents PR Newswire
Grifols, S.A. develops, manufactures, and distributes a range of biological medicines on plasma derived proteins worldwide. The company operates in five segments: Bioscience, Diagnostic, Hospital, Bio Supplies, and Others. The Bioscience segment manufactures plasma derivatives for therapeutic use; and sells and distributes end products. It offers intravenous immune globulin, Factor VIII, alpha-1 proteinase inhibitor, and albumin; and intramuscular immunoglobulins, antithrombin III, Factor IX, and plasma thromboplastin components. The Diagnostic segment focuses on researching, developing, manufacturing, and marketing in vitro diagnostics products, including analytical instruments, reagents, software, and related products for use in clinical and blood bank laboratories. It serves blood donation centers, clinical analysis laboratories, and hospital immunohematology services. The Hospital segment offers products used by hospitals, as well as parenteral solutions and enteral nutritional fluids. The Bio Supplies segment provides biological products for non-therapeutic uses. The Others segment renders manufacturing services to third party companies. The company also provides infusion solutions, nutrition products, and medical devices for use in hospitals and clinics; and engineering services. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves hospitals and clinics, group purchasing organizations, governments, and other distributors through sales representatives, marketing partners, and third-party distributors. Grifols, S.A. has a technology collaboration agreement with Mondragon; and a formal collaboration with the United States Biomedical Advanced Research Development Authority, the Food and Drug Administration, and other Federal public health agencies. The company was founded in 1940 and is headquartered in Barcelona, Spain.